Don't Be Alarmed if a Low Anticoagulant Dose is Used to Prevent Recurrent Clots

More patients will use LOW-dose direct oral anticoagulants (DOACs) long-term to prevent recurrent venous thromboembolism (VTE).

Patients who have a VTE are typically treated with warfarin or a DOAC (Eliquis, etc) for 3 months.

This is usually long enough if an initial VTE was caused by a short-term risk...such as a minor trauma or surgery.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote